PRESS RELEASE
News
-
-
-
PRESS RELEASE
EDAG Engineering Group AG: Decline in revenues and EBIT due to ongoing market restraint in the first half of 2025, expansion of defence activities
EDAG Engineering Group AG reports decline in revenues and EBIT for the first half of 2025 due to market restraint, focusing on defence activities for growth -
-
PRESS RELEASE
Avec la stratégie 2026+, la Banque Cler mise sur l’excellence de la distribution, la compétence en matière de placement, la gestion du bilan et la compétence de direction
Bank Cler AG annonce sa stratégie 2026+ axée sur l'excellence de la distribution, la gestion du bilan et les compétences de direction -
-
-
PRESS RELEASE
Positive development across all major KPI: STRABAG on track for profitable growth
STRABAG SE announces positive first half 2025 results with output up by 7% to €8.9 billion, order backlog at €28.4 billion (+13%), and EBIT increased by 58% to €129.4 million. Expansion into Australia contributing to growth -
REGULATED PRESS RELEASE
Biophytis obtient l’autorisation de l’EMA et des autorités belges pour démarrer son essai clinique de phase 3 dans la sarcopénie
Biophytis obtient l’autorisation de l’EMA et des autorités belges pour démarrer son essai clinique de phase 3 dans la sarcopénie. La société se prépare à recruter des patients pour cette étude majeure -
REGULATED PRESS RELEASE
Biophytis Receives EMA and Belgian Regulatory Approval to Initiate Phase 3 Sarcopenia Clinical Trial
Biophytis receives EMA and Belgian regulatory approval for Phase 3 sarcopenia clinical trial, marking a significant milestone in developing therapies for muscle loss in aging individuals
